Inactive Instrument

News ProText Mobility, Inc. Other OTC

Equities

TXTM

US74371E2046

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION	22-11-14	AQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	22-11-01	EQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	22-11-01	AQ
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	22-11-01	CI
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP	22-08-01	AQ
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended	21-12-02	PU
ProText Mobility : Quarterly Report	21-11-21	PU
ProText Mobility : Notification of Late Filing	21-11-15	PU
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND	21-10-29	AQ
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	21-10-29	CI
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)	20-05-07	NE
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology	20-04-30	NE
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.	19-01-18	CI
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.	18-01-19	GL
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.	18-01-18	CI
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance	17-09-20	MW
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes	17-09-13	MW
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License	17-05-23	MW
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc	17-05-23	CI
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial	17-05-04	MW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ProText Mobility, Inc. Other OTC

Equities

TXTM

US74371E2046

Summary

Filters